Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations

Stergios A. Polyzos,Athanasios D. Anastasilakis,Zoe A. Efstathiadou,Maria P. Yavropoulou,Polyzois Makras

Maturitas（2021）

引用 18|浏览1

暂无评分

摘要

•Postmenopausal osteoporosis may coexist with other metabolic diseases.•Anti-osteoporotic medications may positively or adversely affect metabolic diseases.•Current or emerging medications for metabolic diseases may affect bone metabolism.

查看译文

关键词

BMD,BMI,BMP,CVD,DPP-4i,FN,GLP-1RA,HMG-CoA,HRT,IR,LDL-C,LS,NAFLD,NASH,ONJ,PTH,RANKL,RCT,SERMs,SGLT-2i,T2DM,TBS,TH,ucOC,VTD

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要